KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Operating Leases: 2019-2025

Historic Operating Leases for Guardant Health (GH) over the last 6 years, with Sep 2025 value amounting to $211.8 million.

  • Guardant Health's Operating Leases rose 7.22% to $211.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.8 million, marking a year-over-year increase of 7.22%. This contributed to the annual value of $164.3 million for FY2024, which is 11.60% down from last year.
  • Latest data reveals that Guardant Health reported Operating Leases of $211.8 million as of Q3 2025, which was down 3.13% from $218.6 million recorded in Q2 2025.
  • Guardant Health's 5-year Operating Leases high stood at $241.9 million for Q1 2022, and its period low was $164.3 million during Q4 2024.
  • In the last 3 years, Guardant Health's Operating Leases had a median value of $206.9 million in 2024 and averaged $204.1 million.
  • Its Operating Leases has fluctuated over the past 5 years, first skyrocketed by 443.85% in 2021, then declined by 11.60% in 2024.
  • Over the past 5 years, Guardant Health's Operating Leases (Quarterly) stood at $226.1 million in 2021, then declined by 7.09% to $210.0 million in 2022, then fell by 11.51% to $185.8 million in 2023, then fell by 11.60% to $164.3 million in 2024, then climbed by 7.22% to $211.8 million in 2025.
  • Its last three reported values are $211.8 million in Q3 2025, $218.6 million for Q2 2025, and $190.0 million during Q1 2025.